-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$10.25132.95% Upside
Aquestive Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Aquestive Therapeutics, Inc.?
Aquestive Therapeutics, Inc. has been rated by research analysts at Loop Capital Markets, Piper Sandler, H.C. Wainwright, Oppenheimer in the past 90 days.